Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review

Hereditary cancer syndromes constitute approximately 10% of all cancers. Cascade testing involves testing of at-risk relatives to determine if they carry the familial pathogenic variant. Despite growing efforts targeted at improving cascade testing uptake, current literature continues to reflect poo...

Full description

Saved in:
Bibliographic Details
Main Authors: Chiang, Jianbang, Chua, Ziyang, Chan, Jia Ying, Sule, Ashita Ashish, Loke, Wan Hsein, Lum, Elaine, Ong, Marcus Eng Hock, Graves, Nicholas, Ngeow, Joanne
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2024
Subjects:
Online Access:https://hdl.handle.net/10356/178841
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-178841
record_format dspace
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Medicine, Health and Life Sciences
Cascade testing;
Hereditary tumor syndrome
spellingShingle Medicine, Health and Life Sciences
Cascade testing;
Hereditary tumor syndrome
Chiang, Jianbang
Chua, Ziyang
Chan, Jia Ying
Sule, Ashita Ashish
Loke, Wan Hsein
Lum, Elaine
Ong, Marcus Eng Hock
Graves, Nicholas
Ngeow, Joanne
Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
description Hereditary cancer syndromes constitute approximately 10% of all cancers. Cascade testing involves testing of at-risk relatives to determine if they carry the familial pathogenic variant. Despite growing efforts targeted at improving cascade testing uptake, current literature continues to reflect poor rates of uptake, typically below 30%. This study aims to systematically review current literature on intervention strategies to improve cascade testing, assess the quality of intervention descriptions and evaluate the implementation outcomes of listed interventions. We searched major databases using keywords and subject heading of "cascade testing". Interventions proposed in each study were classified according to the Effective Practice and Organization of Care (EPOC) taxonomy. Quality of intervention description was assessed using the TIDieR checklist, and evaluation of implementation outcomes was performed using Proctor's Implementation Outcomes Framework. Improvements in rates of genetic testing uptake was seen in interventions across the different EPOC taxonomy strategies. The average TIDieR score was 7.3 out of 12. Items least reported include modifications (18.5%), plans to assess fidelity/adherence (7.4%) and actual assessment of fidelity/adherence (7.4%). An average of 2.9 out of 8 aspects of implementation outcomes were examined. The most poorly reported outcomes were cost, fidelity and sustainability, with only 3.7% of studies reporting them. Most interventions have demonstrated success in improving cascade testing uptake. Uptake of cascade testing was highest with delivery arrangement (68%). However, the quality of description of interventions and assessment of implementation outcomes are often suboptimal, hindering their replication and implementation downstream. Therefore, further adoption of standardized guidelines in reporting of interventions and formal assessment of implementation outcomes may help promote translation of these interventions into routine practice.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Chiang, Jianbang
Chua, Ziyang
Chan, Jia Ying
Sule, Ashita Ashish
Loke, Wan Hsein
Lum, Elaine
Ong, Marcus Eng Hock
Graves, Nicholas
Ngeow, Joanne
format Article
author Chiang, Jianbang
Chua, Ziyang
Chan, Jia Ying
Sule, Ashita Ashish
Loke, Wan Hsein
Lum, Elaine
Ong, Marcus Eng Hock
Graves, Nicholas
Ngeow, Joanne
author_sort Chiang, Jianbang
title Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
title_short Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
title_full Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
title_fullStr Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
title_full_unstemmed Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
title_sort strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
publishDate 2024
url https://hdl.handle.net/10356/178841
_version_ 1806059833337577472
spelling sg-ntu-dr.10356-1788412024-07-14T15:37:36Z Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review Chiang, Jianbang Chua, Ziyang Chan, Jia Ying Sule, Ashita Ashish Loke, Wan Hsein Lum, Elaine Ong, Marcus Eng Hock Graves, Nicholas Ngeow, Joanne Lee Kong Chian School of Medicine (LKCMedicine) National Cancer Centre, Singapore Duke-NUS Medical School Medicine, Health and Life Sciences Cascade testing; Hereditary tumor syndrome Hereditary cancer syndromes constitute approximately 10% of all cancers. Cascade testing involves testing of at-risk relatives to determine if they carry the familial pathogenic variant. Despite growing efforts targeted at improving cascade testing uptake, current literature continues to reflect poor rates of uptake, typically below 30%. This study aims to systematically review current literature on intervention strategies to improve cascade testing, assess the quality of intervention descriptions and evaluate the implementation outcomes of listed interventions. We searched major databases using keywords and subject heading of "cascade testing". Interventions proposed in each study were classified according to the Effective Practice and Organization of Care (EPOC) taxonomy. Quality of intervention description was assessed using the TIDieR checklist, and evaluation of implementation outcomes was performed using Proctor's Implementation Outcomes Framework. Improvements in rates of genetic testing uptake was seen in interventions across the different EPOC taxonomy strategies. The average TIDieR score was 7.3 out of 12. Items least reported include modifications (18.5%), plans to assess fidelity/adherence (7.4%) and actual assessment of fidelity/adherence (7.4%). An average of 2.9 out of 8 aspects of implementation outcomes were examined. The most poorly reported outcomes were cost, fidelity and sustainability, with only 3.7% of studies reporting them. Most interventions have demonstrated success in improving cascade testing uptake. Uptake of cascade testing was highest with delivery arrangement (68%). However, the quality of description of interventions and assessment of implementation outcomes are often suboptimal, hindering their replication and implementation downstream. Therefore, further adoption of standardized guidelines in reporting of interventions and formal assessment of implementation outcomes may help promote translation of these interventions into routine practice. Ministry of Health (MOH) National Medical Research Council (NMRC) Published version This research is supported by the Singapore Ministry of Health’s National Medical Research Council Research Training Fellowship. The project is partially funded by NCC Research Fund. 2024-07-09T00:36:23Z 2024-07-09T00:36:23Z 2024 Journal Article Chiang, J., Chua, Z., Chan, J. Y., Sule, A. A., Loke, W. H., Lum, E., Ong, M. E. H., Graves, N. & Ngeow, J. (2024). Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review. Npj Genomic Medicine, 9(1), 26-. https://dx.doi.org/10.1038/s41525-024-00412-0 2056-7944 https://hdl.handle.net/10356/178841 10.1038/s41525-024-00412-0 38570510 2-s2.0-85189474322 1 9 26 en npj Genomic Medicine © 2024 The Author(s). Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. application/pdf